SOX2 and melanoma: Further functional studies revealed that depletion of SOX2 heightened the sensitivity of melanoma cells to BRAFi, while overexpression of a phosphomimetic SOX2-S251E mutant (mimicking constant phosphorylation at Ser251) was sufficient to drive resistance.